27 related articles for article (PubMed ID: 7642582)
1. Crystal structure of the breakpoint cluster region-homology domain from phosphoinositide 3-kinase p85 alpha subunit.
Musacchio A; Cantley LC; Harrison SC
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14373-8. PubMed ID: 8962058
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor 1 (IGF-1) stabilizes nascent blood vessels.
Jacobo SM; Kazlauskas A
J Biol Chem; 2015 Mar; 290(10):6349-60. PubMed ID: 25564613
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphoma.
Liang Z; Diepstra A; Xu C; van Imhoff G; Plattel W; Van Den Berg A; Visser L
PLoS One; 2014; 9(1):e87474. PubMed ID: 24489919
[TBL] [Abstract][Full Text] [Related]
4. Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation.
Girnita L; Worrall C; Takahashi S; Seregard S; Girnita A
Cell Mol Life Sci; 2014 Jul; 71(13):2403-27. PubMed ID: 24276851
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3-kinase (PI3K) activity bound to insulin-like growth factor-I (IGF-I) receptor, which is continuously sustained by IGF-I stimulation, is required for IGF-I-induced cell proliferation.
Fukushima T; Nakamura Y; Yamanaka D; Shibano T; Chida K; Minami S; Asano T; Hakuno F; Takahashi S
J Biol Chem; 2012 Aug; 287(35):29713-21. PubMed ID: 22767591
[TBL] [Abstract][Full Text] [Related]
6. Cell-type-specific roles of IGF-1R and EGFR in mediating Zn2+-induced ERK1/2 and PKB phosphorylation.
Pandey NR; Vardatsikos G; Mehdi MZ; Srivastava AK
J Biol Inorg Chem; 2010 Mar; 15(3):399-407. PubMed ID: 19946718
[TBL] [Abstract][Full Text] [Related]
7. IGF-IR in neuroprotection and brain tumors.
Gualco E; Wang JY; Del Valle L; Urbanska K; Peruzzi F; Khalili K; Amini S; Reiss K
Front Biosci (Landmark Ed); 2009 Jan; 14(1):352-75. PubMed ID: 19273072
[TBL] [Abstract][Full Text] [Related]
8. RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.
Hermanto U; Zong CS; Li W; Wang LH
Mol Cell Biol; 2002 Apr; 22(7):2345-65. PubMed ID: 11884618
[TBL] [Abstract][Full Text] [Related]
9. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis.
Peruzzi F; Prisco M; Dews M; Salomoni P; Grassilli E; Romano G; Calabretta B; Baserga R
Mol Cell Biol; 1999 Oct; 19(10):7203-15. PubMed ID: 10490655
[TBL] [Abstract][Full Text] [Related]
10. Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility.
Mañes S; Mira E; Gómez-Mouton C; Zhao ZJ; Lacalle RA; Martínez-A C
Mol Cell Biol; 1999 Apr; 19(4):3125-35. PubMed ID: 10082579
[TBL] [Abstract][Full Text] [Related]
11. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.
Shepherd PR; Withers DJ; Siddle K
Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):471-90. PubMed ID: 9677303
[TBL] [Abstract][Full Text] [Related]
12. Interaction in vitro of the product of the c-Crk-II proto-oncogene with the insulin-like growth factor I receptor.
Koval AP; Blakesley VA; Roberts CT; Zick Y; Leroith D
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):923-32. PubMed ID: 9480911
[TBL] [Abstract][Full Text] [Related]
13. The adapter protein Grb10 associates preferentially with the insulin receptor as compared with the IGF-I receptor in mouse fibroblasts.
Laviola L; Giorgino F; Chow JC; Baquero JA; Hansen H; Ooi J; Zhu J; Riedel H; Smith RJ
J Clin Invest; 1997 Mar; 99(5):830-7. PubMed ID: 9062339
[TBL] [Abstract][Full Text] [Related]
14. Localization of the insulin-like growth factor I receptor binding sites for the SH2 domain proteins p85, Syp, and GTPase activating protein.
Seely BL; Reichart DR; Staubs PA; Jhun BH; Hsu D; Maegawa H; Milarski KL; Saltiel AR; Olefsky JM
J Biol Chem; 1995 Aug; 270(32):19151-7. PubMed ID: 7642582
[TBL] [Abstract][Full Text] [Related]
15. Localization of the insulin receptor binding sites for the SH2 domain proteins p85, Syp, and GAP.
Staubs PA; Reichart DR; Saltiel AR; Milarski KL; Maegawa H; Berhanu P; Olefsky JM; Seely BL
J Biol Chem; 1994 Nov; 269(44):27186-92. PubMed ID: 7525547
[TBL] [Abstract][Full Text] [Related]
16. Reexamining interaction of the SH2 domains of SYP and GAP with insulin and IGF-1 receptors in the two-hybrid system.
Lamothe B; Bucchini D; Jami J; Joshi RL
Gene; 1996 Dec; 182(1-2):77-80. PubMed ID: 8982070
[TBL] [Abstract][Full Text] [Related]
17. A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner.
Zhang-Sun G; Yang C; Viallet J; Feng G; Bergeron JJ; Posner BI
Endocrinology; 1996 Jul; 137(7):2649-58. PubMed ID: 8770882
[TBL] [Abstract][Full Text] [Related]
18. Characterization and cloning of a 58/53-kDa substrate of the insulin receptor tyrosine kinase.
Yeh TC; Ogawa W; Danielsen AG; Roth RA
J Biol Chem; 1996 Feb; 271(6):2921-8. PubMed ID: 8621681
[TBL] [Abstract][Full Text] [Related]
19. In vitro association of the phosphatidylinositol 3-kinase regulatory subunit (p85) with the human insulin receptor.
Ottinger EA; Hui TY; Man Z; Barany G; Bernlohr DA
Int J Pept Protein Res; 1995 Nov; 46(5):346-53. PubMed ID: 8567177
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
